Moleac Pte Ltd.
🇸🇬Singapore
- Country
- 🇸🇬Singapore
- Ownership
- Holding
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.moleac.com
CognivAiD Real-World Evidence Clinical Registry (CONNECT Registry)
Recruiting
- Conditions
- Memory ImpairmentDementia, Vascular
- First Posted Date
- 2024-01-29
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT06228638
- Locations
- 🇸🇬
Raffles Hospital, Singapore, Singapore
MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits
Phase 2
Recruiting
- Conditions
- Strokes ThromboticStroke, IschemicStroke, EmbolicStroke, CryptogenicStrokeStroke, CardiovascularStroke Sequelae
- Interventions
- Other: PlaceboDrug: MLC1501
- First Posted Date
- 2022-03-22
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT05289947
- Locations
- 🇵ðŸ‡
West Visayas State University Medical Center, Iloilo City, Philippines
🇸🇬Singapore General Hospital, Singapore, Singapore
🇸🇬Raffles Hospital, Singapore, Singapore
MLC1501 Study Assessing Efficacy in STROke Recovery
Phase 2
Not yet recruiting
- Conditions
- StrokeStroke, CardiovascularStroke, CryptogenicStroke, EmbolicStroke, IschemicStrokes ThromboticStroke Sequelae
- Interventions
- Other: PlaceboDrug: MLC1501
- First Posted Date
- 2021-09-16
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 540
- Registration Number
- NCT05046106
NeuroAiD IIâ„¢ (MLC901) in Mild Traumatic Brain Injury
Phase 3
Completed
- Conditions
- Traumatic Brain Injury
- Interventions
- Other: PlaceboCombination Product: Traditional Chinese Medicine (NeuroAiD IIâ„¢ (MLC901)
- First Posted Date
- 2021-04-27
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 182
- Registration Number
- NCT04861688
- Locations
- 🇷🇺
State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation
🇷🇺Nizhny Novgorod regional clinical hospital named after N. A. Semashko, Nizhny Novgorod, Russian Federation
🇷🇺Municipal Polyclinic № 106 of St.Petersburg, Saint Petersburg, Russian Federation
Drug-Drug Interaction Study of MLC1501 Using Cocktail of Drugs Acting as Sensitive Clinical Probes/Substrates of Cytochrome P450 Isoenzymes and Transporters in Healthy Subjects
Phase 1
Completed
- Conditions
- Stroke
- Interventions
- Drug: MLC1501Drug: Transporter CocktailDrug: CYP Cocktail
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 27
- Registration Number
- NCT04233437
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia
Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD
Phase 4
Completed
- Conditions
- Spinal Cord Injury
- Interventions
- Drug: NeuroAiD
- First Posted Date
- 2015-09-02
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT02537899
- Locations
- 🇲🇾
University Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
Study of NeuroAid In Enhancing Recovery After Stroke
Phase 2
Completed
- Conditions
- StrokeCerebral Infarction
- Interventions
- Drug: NeuroaidDrug: Neuroaid matched Placebo
- First Posted Date
- 2008-07-24
- Last Posted Date
- 2008-07-24
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT00721825
- Locations
- 🇸🇬
Tan Tock Seng Rehabilitation department, Singapore, Singapore
© Copyright 2025. All Rights Reserved by MedPath